Knox Kari, Stanley Justin, Hendrix James A, Hillerstrom Hampus, Dunn Taylor, Achenbach Jillian, Chicoine Brian A, Lai Florence, Lott Ira, Stanojevic Sanja, Howlett Susan E, Rockwood Kenneth
DGI Clinical Inc, 300SH-1701 Hollis St, Halifax, NS, B3J 3M8, Canada.
LuMind IDSC Foundation, Burlington, MA, USA.
J Patient Rep Outcomes. 2021 Jan 11;5(1):5. doi: 10.1186/s41687-020-00278-7.
As life expectancy of people with Down syndrome (DS) increases, so does the risk of Alzheimer's disease (AD). Identifying symptoms and tracking disease progression is especially challenging whenever levels of function vary before the onset of dementia. Goal Attainment Scaling (GAS), an individualized patient-reported outcome, can aid in monitoring disease progression and treatment effectiveness in adults with DS. Here, with clinical input, a validated dementia symptom menu was revised to facilitate GAS in adults living with Down Syndrome-associated Alzheimer's disease (DS-AD).
Four clinicians with expertise in DS-AD and ten caregivers of adults living with DS-AD participated in semi-structured interviews to review the menu. Each participant reviewed 9-15 goal areas to assess their clarity and comprehensiveness. Responses were systematically and independently coded by two researchers as 'clear', 'modify', 'remove' or 'new'. Caregivers were encouraged to suggest additional items and recommend changes to clarify items.
Median caregiver age was 65 years (range 54-77). Most were female (9/10) with ≥15 years of education (10/10). Adults with DS-AD had a median age of 58 years (range 52-61) and either a formal diagnosis (6/10) or clinical suspicion (4/10) of dementia. The initial symptom menu consisted of 67 symptoms each with 2-12 descriptors (589 total). The clinicians' adaptation yielded 58 symptoms each with 4-17 descriptors (580 total). Of these 580 descriptors, caregivers identified 37 (6%) as unclear; these were reworded, and one goal area (4 descriptors) was removed. A further 47 descriptors and one goal area were added to include caregiver-identified concepts. The final menu contained 58 goal areas, each with 7-17 descriptors (623 total).
A comprehensive symptom menu for adults living with DS-AD was developed to facilitate GAS. Incorporating expert clinician opinion and input from caregivers of adults with DS-AD identified meaningful items that incorporate patient/caregiver perspectives.
随着唐氏综合征(DS)患者预期寿命的延长,患阿尔茨海默病(AD)的风险也在增加。每当痴呆症发作前功能水平发生变化时,识别症状和跟踪疾病进展尤其具有挑战性。目标达成量表(GAS)是一种个体化的患者报告结局,可有助于监测DS成人患者的疾病进展和治疗效果。在此,在临床意见的基础上,对经过验证的痴呆症状菜单进行了修订,以促进对患有唐氏综合征相关阿尔茨海默病(DS-AD)的成年人进行目标达成量表评估。
四名具有DS-AD专业知识的临床医生和十名DS-AD成年患者的护理人员参与了半结构化访谈,以审查该菜单。每位参与者审查了9-15个目标领域,以评估其清晰度和全面性。两名研究人员将回答系统地、独立地编码为“清晰”、“修改”、“删除”或“新增”。鼓励护理人员提出额外的项目并建议进行修改以澄清项目。
护理人员的年龄中位数为65岁(范围54-77岁)。大多数为女性(9/10),接受过≥15年的教育(10/10)。患有DS-AD的成年人年龄中位数为58岁(范围52-61岁),患有痴呆症的确诊(6/10)或临床疑似病例(4/10)。最初的症状菜单包括67种症状,每种症状有2-12个描述符(共589个)。临床医生的调整产生了58种症状,每种症状有4-17个描述符(共580个)。在这580个描述符中,护理人员将37个(6%)确定为不清晰;这些描述符被重新措辞,一个目标领域(4个描述符)被删除。又增加了47个描述符和一个目标领域,以纳入护理人员确定的概念。最终菜单包含58个目标领域,每个领域有7-17个描述符(共623个)。
制定了一份针对患有DS-AD的成年人的综合症状菜单,以促进目标达成量表评估。纳入临床医生的专业意见和DS-AD成年患者护理人员的意见,确定了纳入患者/护理人员观点的有意义项目。